IOTOD: Autumn Webinar

Press Release

Developed by PCM Scientific, the IOTOD autumn webinar will be looking at perspectives from both opioid-dependent treatment providers and patients surrounding the use of long-acting buprenorphine (LAB) in different treatment scenarios and treatment journey stages.

IOTOD

Following on from the success of our summer webinar and annual conference, we are pleased to announce that the IOTOD autumn webinar ‘Transfer to long-acting buprenorphine from full opioid agonists in different dependent demographics: do’s, don’ts, and why does it matter?’ will be taking place on Monday 25th October 13:00 BST on Zoom.

This autumn educational session will be led by US-based Dr Michael Frost and joined by Professor Michael Soyka who is based in Germany. This webinar will be looking at perspectives from both opioid-dependent treatment providers and patients surrounding the use of long-acting buprenorphine (LAB) in different treatment scenarios and treatment journey stages.

They will also discuss best practice approaches for transferring patients from daily dose methadone or buprenorphine to LAB, potential transfer outcomes and next steps. The event will conclude with a lively Q&A session.

The IOTOD webinar was supported by arms-length funding from Camurus and the archived version will soon be available on the IOTOD website.